# FMC Corp: Form 10-Q for the period ended Sep 30, 2015

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2015-11-02
- Accepted by EDGAR: Nov 2, 2015, 20:40 ET
- Period: 2015-09-30
- Accession: 0000037785-15-000077
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778515000077/fmc930201510q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778515000077/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-07-01 to 2015-09-30 | $830.7m | us-gaap:Revenues |
| Revenue | 9 months, 2015-01-01 to 2015-09-30 | $2.38bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-07-01 to 2015-09-30 | $610.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2015-01-01 to 2015-09-30 | $1.60bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2015-07-01 to 2015-09-30 | $220.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2015-01-01 to 2015-09-30 | $776.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2015-07-01 to 2015-09-30 | $137.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2015-01-01 to 2015-09-30 | $590.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-07-01 to 2015-09-30 | $500.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2015-01-01 to 2015-09-30 | $4.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2015-07-01 to 2015-09-30 | −$25.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2015-01-01 to 2015-09-30 | −$56.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-07-01 to 2015-09-30 | −$2.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | $693.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | $5.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-07-01 to 2015-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2015-01-01 to 2015-09-30 | $5.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-07-01 to 2015-09-30 | 134,375,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2015-01-01 to 2015-09-30 | 133,679,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | −$246.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $87.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2015-01-01 to 2015-09-30 | $64.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2015-09-30 | $173.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $3.24bn | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $6.45bn | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $1.46bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2015-09-30 | $2.05bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-09-30 | $1.4m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2015-09-30 | $119.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2015-09-30 | $2.11bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2015-09-30 | 133,622,997 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 67,693 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, "expect", “expects”, “should”, “could”, “may”, “will continue to”, "believe", “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and

unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of

activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part II included in this Form 10-Q may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2014 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2014 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

Subsequent to the acquisition of Cheminova and divestiture of our FMC Alkali Chemicals division (see Note 3 and Note 9 to the condensed consolidated financial statements included within this Form 10-Q for more information) we have reassessed our critical accounting policies. We have concluded that in addition to the four critical accounting policies listed above that our accounting policy over "Revenue recognition and trade receivables" is now critical to our results of operations and financial condition.

### Revenue recognition and trade receivables

We recognize revenue when the earnings process is complete, which is generally upon transfer of title. This transfer typically occurs either upon shipment to the customer or upon receipt by the customer. In all cases, we apply the following criteria in recognizing revenue: persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable and collection is reasonably assured. Rebates due to customers are accrued as a reduction of revenue in the same period that the related sales are recorded based on the contract terms.

We periodically enter into prepayment arrangements with customers, primarily in our FMC Agricultural Solutions segment, and receive advance payments for product to be delivered in future periods. These advance payments are recorded as deferred revenue and classified as “Advance payments from customers” on the consolidated balance sheet. Revenue associated with advance payments is recognized as shipments are made and title, ownership and risk of loss pass to the customer.

We record amounts billed for shipping and handling fees as revenue. Costs incurred for shipping and handling are recorded as costs of sales and services. Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from sales in the consolidated income statements. We record a liability until remitted to the respective taxing authority.

Trade receivables consist of amounts owed to us from customer sales and are recorded when revenue is recognized. The allowance for trade receivables represents our best estimate of the probable losses associated with potential customer defaults. In developing our allowance for trade receivables, we utilize a two stage process which includes calculating a general formula to develop an allowance to appropriately address the uncertainty surrounding collection risk of our entire portfolio and specific allowances for customers where the risk of collection has been reasonably identified either due to liquidity constraints or disputes over contractual terms and conditions.

Our method of calculating the general formula consists of estimating the recoverability of trade receivables based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. Our analysis of trade receivable collection risk is performed quarterly, and the allowance is adjusted accordingly.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The FMC Health and Nutrition segment focuses on food, pharmaceutical ingredients, nutraceuticals, personal care and similar markets. Our food ingredients are used to enhance texture, color, structure and physical stability. The pharmaceutical additives are used for binding, encapsulation and disintegrant applications. Our FMC Lithium segment produces a wide range of products based on lithium.

### Third Quarter 2015 Highlights

The following are the more significant developments in our businesses during the three months ended September 30, 2015:

- Revenue of $830.7 million for the three months ended September 30, 2015 increased $12 million or one percent versus the same period last year. The increase in revenue was attributable to FMC Agricultural Solutions and the acquisition of Cheminova, completed in April 2015. Partially offsetting the addition of the Cheminova revenues were unfavorable currency movements, primarily in our FMC Agricultural Solutions segment within Brazil. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America decreased 11 percent period over period while sales in Asia improved by 34 percent, sales in Latin America decreased 18 percent and sales in Europe, Middle East and Africa increased by 46 percent primarily due to the acquisition of Cheminova.
- Our gross margin, excluding acquisition-related charges, decreased by approximately $34 million or approximately twelve percent to $249 million versus last prior year's quarter. Gross margin percent of 30 percent declined from 35 percent. The reduction in gross margin was due to lower volumes in Brazil within FMC Agricultural Solutions. The gross margin percentage decline was driven primarily by unfavorable currency movements.
- Selling, general and administrative expenses, excluding acquisition-related charges and non-operating pension and postretirement charges increased by approximately $15 million or 14 percent to $117 million. The increase was driven primarily by the acquisition of Cheminova which is being integrated into our FMC Agricultural Solutions segment.
- Research and Development expenses of $37 million increased $7 million or 23 percent.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $56.4 million decreased by $40 million or 41 percent primarily due to lower operating results in FMC Agricultural Solutions. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### Other Highlights

- On September 8, 2015, we entered into a definitive agreement to sell our generic crop protection business in Brazil, Consagro, to Atanor do Brasil Ltda., the Brazilian subsidiary of Albaugh, LLC. The sale of Consagro is part of our broad strategy to focus on our portfolio of valued-added products, especially with the addition of the Cheminova product line in Brazil. We expect the sale to occur in the fourth quarter of 2015.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2015 Revenue | Three Months Ended September 30 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $577.6 | $548.8 | $1,595.6 | $1,546.9 |
| FMC Health and Nutrition | 195.9 | 203.1 | 613.5 | 636.4 |
| FMC Lithium | 57.2 | 67.2 | 168.1 | 187.6 |
| **Total** | **$830.7** | **$819.1** | **$2,377.2** | **$2,370.9** |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| FMC Agricultural Solutions | $59.4 | $116.7 | $262.6 | $367.5 |
| FMC Health and Nutrition | 47.0 | 43.7 | 148.5 | 143.7 |
| FMC Lithium | 1.8 | 5.3 | 11.9 | 19.4 |
| **Segment operating profit** | **$108.2** | **$165.7** | **$423.0** | **$530.6** |
| Corporate and other | (13.6) | (15.2) | (46.0) | (52.1) |
| **Operating profit before the items listed below** | **$94.6** | **$150.5** | **$377.0** | **$478.5** |
| Interest expense, net | (20.2) | (12.8) | (58.9) | (37.6) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income (1) | (45.6) | (35.6) | (78.2) | (44.9) |
| Non-operating pension and postretirement charges (2) | (5.5) | (1.5) | (19.9) | (8.4) |
| Business separation costs (3) | — | (6.8) | — | (23.6) |
| Acquisition-related charges (4) | (43.0) | (36.5) | (274.0) | (40.7) |
| (Provision) benefit for income taxes | 25.1 | (3.6) | 56.4 | (74.6) |
| Discontinued operations, net of income taxes | (5.0) | 6.4 | 698.8 | (4.9) |
| Net income attributable to noncontrolling interests | (2.8) | (3.8) | (8.1) | (12.8) |
| **Net income (loss) attributable to FMC stockholders** | **$(2.4)** | **$56.3** | **$693.1** | **$231.0** |

(1) See Note 7 for details of restructuring and other charges (income). Below provides the detail the charges (income) by segment:

*(in Millions)*

|  | Three Months Ended September 30 2015 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $(24.1) | $(17.0) | $(47.2) | $(17.0) |
| FMC Health and Nutrition | (16.6) | — | (20.6) | (5.9) |
| FMC Lithium | — | (0.1) | (0.5) | — |
| Corporate | (4.9) | (18.5) | (9.9) | (22.0) |
| **Restructuring and other (charges) income** | $(45.6) | $(35.6) | $(78.2) | $(44.9) |

(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss).

(3) On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three and nine months ended September 30, 2014 represent charges associated with the planned separation activities through September 30, 2014.

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, transaction costs, costs for transitional employees, other acquired employee related costs, integration related legal and professional third-party fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

*(in Millions)*

| Acquisition-related charges - Cheminova | Three Months Ended September 30 2015 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Legal and professional fees (1) | $14.2 | $15.3 | $53.8 | $15.3 |
| Inventory fair value amortization (2) | 28.8 | — | 48.1 | — |
| (Gain)/loss on hedging purchase price (1) | — | 21.2 | 172.1 | 21.2 |
| Acquisition-related charges - Epax |  |  |  |  |
| Inventory fair value amortization (2) | — | — | — | 4.2 |
| **Acquisition-related charges** | **$43.0** | **$36.5** | **$274.0** | **$40.7** |

(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expenses.” For more information on the loss on purchase price hedge see Note 3 to the condensed consolidated financial statements included within this Form 10-Q.

(2) On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income (loss) attributable to FMC stockholders.” We believe that this measure provides useful information about our operating results to investors. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2015 | Three Months Ended September 30 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| **Net income (loss) attributable to FMC stockholders (GAAP)** | $(2.4) | $56.3 | $693.1 | $231.0 |
| Corporate special charges (income), pre-tax | 94.1 | 80.4 | 372.1 | 117.6 |
| Income tax expense (benefit) on Corporate special charges (income) | (13.7) | (27.7) | (113.8) | (40.8) |
| Corporate special charges (income), net of income taxes | $80.4 | $52.7 | $258.3 | $76.8 |
| Discontinued operations attributable to FMC Stockholders, net of income taxes | 5.0 | (4.7) | (698.8) | 10.1 |
| Non-GAAP tax adjustments (1) | (26.6) | (7.9) | (23.7) | (5.4) |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | **$56.4** | **$96.4** | **$228.9** | **$312.5** |

(1) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to ongoing business operations in the current year; unusual or infrequently occurring items; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition-related charges, and other income and expense items.

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 17 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2014 Form 10-K.

### FMC Agricultural Solutions

*(in Millions)*

| 2015 | Three Months Ended September 30 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $577.6 | $548.8 | $1,595.6 | $1,546.9 |
| Operating Profit | 59.4 | 116.7 | 262.6 | 367.5 |

### Three months ended September 30, 2015 vs. 2014

Revenue of $577.6 million increased approximately five percent versus the prior year quarter due to the revenue from the Cheminova acquisition on April 20, 2015.

FMC Agricultural Solutions' operating profit of $59.4 million decreased approximately 49 percent compared to the year-ago quarter. This decline was driven by market conditions primarily in Brazil.

Refer to the ***FMC Agricultural Solutions Proforma Financial Results with Cheminova*** section below for further discussion.

### Nine months ended September 30, 2015 vs. 2014

Revenue of $1,595.6 million increased approximately three percent versus the prior year period. Consistent with the three month explanation above, the increase was primarily driven by the addition of revenues from the Cheminova acquisition.

FMC Agricultural Solutions' operating profit of $262.6 million decreased approximately 29 percent compared to the year-ago quarter. This decline was driven by market conditions primarily in Brazil.

Refer to the ***FMC Agricultural Solutions Proforma Financial Results with Cheminova*** section below for further discussion.

### FMC Agricultural Solutions Pro forma Financial Results with Cheminova

In the second quarter of 2015, we began to present pro forma combined results for the FMC Agricultural Solutions segment for 2015 and 2014. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for 2015 and 2014 is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the Cheminova transaction had occurred on January 1, 2014. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for cost related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated Cheminova since January 1, 2014, nor our future results. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for these interim periods is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of the segment.

*FMC Agricultural Solutions Pro Forma Financial Results*

*(in Millions)*

| Revenue | Three Months Ended September 30 2015 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue, FMC Agricultural Solutions, as reported (1) | $577.6 | $548.8 | $1,595.6 | $1,546.9 |
| Revenue, Cheminova, pro forma (2) | — | 305.4 | 362.0 | 999.1 |
| **Pro Forma Combined, Revenue (3)** | **$577.6** | **$854.2** | **$1,957.6** | **$2,546.0** |
| **Operating Profit** |  |  |  |  |
| Operating Profit, FMC Agricultural Solutions, as reported (1) | $59.4 | $116.7 | $262.6 | $367.5 |
| Operating Profit, Cheminova, pro forma (2) |  | (1.4) | 19.9 | 58.1 |
| **Pro Forma Combined, Operating Profit (3)** | **$59.4** | **$115.3** | **$282.5** | **$425.6** |

(1) As reported amounts are the results of operations of FMC Agricultural Solutions, including the results of the Cheminova acquisition from April 21, 2015 onward.

(2) Cheminova pro forma amounts include the historical results of Cheminova, prior to April 21, 2015. These amounts also include adjustments as if the Cheminova transaction had occurred on January 1, 2014, including the effects of acquisition accounting. The pro forma amounts do not include adjustments for expenses related to integration activities, cost savings or synergies that may have been or may be achieved by the combined segment.

(3) The pro forma combined amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2014 or indicative of future results.

*FMC Agricultural Solutions Pro Forma Combined Revenue by Region (1)*

*(in Millions)*

|  | Three Months Ended September 30 2015 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Europe, Middle East and Africa (EMEA) | $85.2 | $121.9 | $486.9 | $593.6 |
| North America | 50.2 | 73.1 | 456.6 | 521.2 |
| Latin America | 322.4 | 523.8 | 619.7 | 974.6 |
| Asia | 119.8 | 135.4 | 394.4 | 456.6 |
| **Total** | **$577.6** | **$854.2** | **$1,957.6** | **$2,546.0** |

(1) The pro forma combined revenue by region amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2014 or indicative of future results.

### Pro Forma Combined Results - Three months ended September 30, 2015 vs. 2014

Pro forma combined revenue of $577.6 million decreased by approximately 32 percent versus the prior year quarter. Favorable

pricing impacted revenue by seven percent in 2015 compared to the same period in 2014; however, the price increases only partially offset the unfavorable impact of foreign currency movements and lower volumes. Unfavorable currency negatively impacted revenue 15 percent while volumes impacted it by 25 percent. Most of this decline was experienced in Latin America, primarily Brazil.

Pro forma combined operating profit of $59.4 million decreased approximately 48 percent compared to the year-ago quarter. The significant movement in foreign exchange rates compared to last year, particularly the real, was the main driver of the

decline in operating profit as price increases in local currencies were not enough to offset the impact of foreign currency. During the third quarter alone, the real depreciated over 25 percent versus the U.S. dollar. As a result, foreign currency contributed approximately 94 percent to the decline in year over year pro forma combined operating profit while to a lesser extent lower volumes contributed a 38 percent impact. As discussed, higher pricing and mix offset these declines by 52 percent while lower costs primarily selling, general and administrative in nature improved profits year over year by 31 percent.

During the quarter, FMC Agricultural Solutions announced several targeted measures to reduce operating costs and reorganize our operations in Brazil to align the business with near-term market conditions. These measures include:

- Enhancing our focus on proprietary technology platforms and differentiated products, and rationalizing our product offerings to eliminate low-margin sales. This portfolio rationalization program, including the previously announced sale of our generic subsidiary, Consagro, will reduce 2015 revenue in Brazil by $250 million compared to 2014. This will enable us to further reduce the region's operating costs and enhance our potential to deliver higher future earnings and return on capital. At the completion of this reorganization, FMC's workforce in Brazil will be approximately half its size compared to 2014. All of these actions will be substantially completed by year-end.
- The Cheminova integration will be accelerated and additional programs to achieve further cost savings will be implemented, commencing immediately.

### Pro Forma Combined Results - Nine months ended September 30, 2015 vs. 2014

Pro Forma combined revenue of $1,957.6 million decreased approximately 23 percent versus the prior year period. Drivers for the decrease year over year, as well as the percentage impact, were consistent with the three months ended as described in the discussion above.

Pro forma combined operating profit of $282.5 million decreased approximately 34 percent compared to the year-ago period. Drivers for the decrease year over year, as well as the percentage impact, were consistent with the three months ended as described in the discussion above.

### Outlook

We expect full year 2015 Agricultural Solutions revenue of approximately $2.3 billion and expect full year segment operating profit of $370 to $390 million. This translates into full year pro forma combined revenue of approximately $2.7 billion and full year pro forma combined operating profit of $390 to $410 million. We expect much of the foreign currency headwinds that impacted the Agricultural Solutions third quarter 2015 results to persist through the end of the year. However, we expect to realize a significant portion of the 2015 cost savings associated with the integration of Cheminova in the fourth quarter 2015. These costs savings, combined with additional price increases and ongoing portfolio rationalization, will largely offset the foreign currency headwinds we are facing in Latin America. Outside of Latin America, we expect the business to be flat to 2014.

#### Certain Regulatory Issues

A detailed discussion related to regulatory issues impacting FMC Agricultural Solutions can be found in Part II, Item 7 of our 2014 Form 10-K. There have been no material changes related to regulatory issues impacting FMC Agricultural Solutions from the information reported in our 2014 10-K.

### FMC Health and Nutrition

*(in Millions)*

| 2015 | Three Months Ended September 30 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $195.9 | $203.1 | $613.5 | 636.4 |
| Operating Profit | 47.0 | 43.7 | 148.5 | 143.7 |

### Three months ended September 30, 2015 vs. 2014

Revenue of $195.9 million decreased approximately four percent versus the prior-year quarter. Unfavorable foreign currency impacts, primarily a weaker euro, decreased revenue by approximately five percent. The decrease was offset by higher volumes and favorable product mix, driven by the MCC family of products in both pharmaceuticals and food end markets, which impacted revenue by approximately one percent. Pricing for the three months ended 2015 as compared to 2014 was slightly positive.

Segment operating profit of $47.0 million increased approximately eight percent versus the year ago quarter driven by favorable volume, improved sales mix and lower Selling, General, and Administrative (SG&A) costs, partially offset by unfavorable currency. Higher volumes and favorable mix impacted segment operating profit by six percent. Cost saving initiatives in SG&A and Research and Development (R&D) impacted segment operating profit by four percent. Unfavorable currency impacts reduced segment operating profit by three percent.

### Nine months ended September 30, 2015 vs. 2014

Revenue was $613.5 million, a decrease of approximately four percent versus the prior-year period. Unfavorable foreign currency impacts, primarily a weaker euro, decreased revenue by approximately six percent, partially offset by higher volumes impacting revenue by approximately two percent.

Segment operating profit of $148.5 million increased approximately three percent versus the year ago quarter driven by the higher volumes discussed in the preceding paragraph.

### Outlook

We expect full year 2015 Health and Nutrition revenue of approximately $800 million and expect full year segment operating profit of $193 to 195 million. Revenue is expected to be lower by three percent compared to full year 2014, mostly driven by unfavorable foreign currency. However, full year segment operating profit is expected to be four percent higher driven by continue demand for MCC product lines and lower operating costs as a result of ongoing manufacturing improvement programs.

### FMC Lithium

*(in Millions)*

| 2015 | Three Months Ended September 30 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $57.2 | $67.2 | $168.1 | $187.6 |
| Operating Profit | 1.8 | 5.3 | 11.9 | 19.4 |

### Three months ended September 30, 2015 vs. 2014

Revenue of $57.2 million decreased by approximately 15 percent versus the prior-year quarter driven by unfavorable foreign currency impacts and lower sales volumes. Unfavorable foreign currency impacted revenue by three percent while lower volumes impacted revenue by 13 percent. Lower sales volumes were due to lower carbonate sales and the timing of a scheduled maintenance outage of our lithium hydroxide unit in Bessemer City, NC.

Segment operating profit of $1.8 million decreased approximately 66 percent versus the year ago quarter. Foreign currency, specifically the Argentine peso and the euro, continue to have a significant negative impact on segment operating profit. Foreign currency impacted segment operating profit by 50 percent compared to the year ago quarter. These impacts and the lower volumes mentioned above were partially offset by favorable operating performance.

### Nine months ended September 30, 2015 vs. 2014

Revenue of $168.1 million decreased by approximately 10 percent versus the prior-year quarter driven by lower volumes of upstream products and weaker foreign currencies. These impacted revenues by 10 percent and three percent, respectively. These impacts were partially offset by favorable pricing which impacted revenue by three percent.

Segment operating profit of $11.9 million decreased approximately 39 percent versus the year ago quarter driven by the same factors as noted in the three months discussion above.

### Outlook

We expect full year 2015 Lithium revenue of approximately $240 million and expect full year segment operating profit of $16 to 18 million. We continue to see strong demand for our specialty products and expect sequentially higher carbonate and hydroxide volumes as well as higher selling prices. Inflationary pressures in Argentina are expected to continue but going forward we expect them to be offset by lower manufacturing costs.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).

### Three months ended September 30, 2015 vs. 2014

Corporate and other expenses of $13.6 million in the third quarter of 2015 decreased by $1.6 million from $15.2 million in the same period in 2014. The decrease is driven by favorable foreign exchange impacts of $3.1 million and $1.3 million of income associated with the transitional services agreement with Tronox for the sale of the FMC Alkali Chemicals division.

### Nine months ended September 30, 2015 vs. 2014

Corporate and other expenses of $46.0 million in the nine months of 2015 decreased by $6.1 million from $52.1 million in the same period in 2014. The decrease is driven by favorable foreign exchange impacts of $2.4 million as well as $2.3 million of income associated with the Tronox transitional services agreement.

#### Interest expense, net

### Three months ended September 30, 2015 vs. 2014

Interest expense, net for the third quarter of 2015 was $20.2 million as compared to the third quarter of 2014 of $12.8 million. The increase was primarily due to our borrowings under the previously announced senior unsecured Term Loan facility. The proceeds of the borrowing were used to finance the acquisition of Cheminova as well as to pay costs, fees and expenses incurred in connection with the acquisition and the term loan facility. See Note 8 within the condensed consolidated financial statements included in this Form 10-Q for more information.

### Nine months ended September 30, 2015 vs. 2014

Interest expense, net for the nine months of 2015 was $58.9 million as compared to the first half of 2014 of $37.6 million. The increase is consistent with the description provided for the three months ended period noted above.

#### Corporate special (charges) income

### Three months ended September 30, 2015 vs. 2014

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended September 30 2015 | 2014 | Nine Months Ended September 30 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges and asset disposals | $69.3 | $1.3 | $81.5 | $7.9 |
| Other charges (income), net | (23.7) | 34.3 | (3.3) | 37.0 |
| Total restructuring and other charges | $45.6 | $35.6 | $78.2 | $44.9 |

Restructuring and asset disposal charges in 2015 of $69.3 million were primarily associated with the Cheminova restructuring that was implemented as part of the integration of Cheminova into our existing FMC Agricultural Solutions segment for the quarter, this consisted primarily of the Consagro impairment of $40.1 million. Other charges (income) net in 2015 of $(23.7) million were primarily related to the sale of our remaining ownership interest in a Belgian-based pesticide distribution company, Belchim Crop Protection N.V. ("Belchim"). See Note 7 within the condensed consolidated financial statements included in this Form 10-Q for more information.

Restructuring and asset disposal charges in 2014 of $1.3 million were primarily associated with the Health and Nutrition restructuring. Other charges (income) net in 2014 of $34.3 million were primarily related to corporate environmental charges and charges associated with an exclusive license, development and supply agreement for a novel crop protection product for agricultural use in the United States. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

The liabilities associated with the restructuring charges listed above are also included within Note 7 to the condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended September 30, 2015 was $5.5 million compared to $1.5 million for the three months ended September 30, 2014. The increase in charges was primarily the result of higher amortization impacts of actuarial losses. See Note 13 to the condensed consolidated financial statements included in this Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).

#### Business separation costs

On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova and divestiture of our FMC Alkali Chemicals division. As a result there were no business separation charges in 2015. Business separation costs for the three months ended September 30, 2014 represent charges associated with the planned separation activities through September 30, 2014.

#### Acquisition-related charges

A detailed description of the acquisition-related charges is included in Note 17 to the condensed consolidated financial statements included within this Form 10-Q.

### Nine months ended September 30, 2015 vs. 2014

#### Restructuring and other charges (income)

Restructuring and asset disposal charges in 2015 of $81.5 million were consistent with the description provided for the three months ended period noted above. Other charges (income) net in 2015 of $(3.3) million included a $15.0 million charge for the acquisition of all global rights to a pre-development novel, proprietary broadleaf herbicide. This acquisition is considered as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination. Offsetting this charge was income of $26.6 million from the sale of our remaining ownership interest in a Belgian-based pesticide distribution company, Belchim Crop Protection N.V. ("Belchim"). See Note 7 within the condensed consolidated financial statements included in this Form 10-Q for more information. Other charges (income) net in 2015 also included corporate environmental charges.

Restructuring and asset disposal charges in 2014 of $7.9 million were primarily associated with the Health and Nutrition restructuring. Other charges (income) net in 2014 of $37.0 million were primarily related to corporate environmental charges.

#### Non-operating pension and postretirement charges

The charge for the nine months ended September 30, 2015 was $19.9 million compared to $8.4 million for the nine months ended September 30, 2014. The increase is consistent with the description provided for the three months ended period noted above.

#### Business separation costs

On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova and divestiture of our FMC Alkali Chemicals division. Business separation costs for the nine months ended September 30, 2014 represent charges associated with the planned separation activities through September 30, 2014.

#### Acquisition-related charges

A detailed description of the acquisition-related charges is included in Note 17 to the condensed consolidated financial statements included within this Form 10-Q.

#### Provision for income taxes

A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Denmark, Ireland and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; closure of statute of limitations or settlement of tax audits; changes in valuation allowance and changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States taxes have not been previously accrued.

### Three months ended September 30, 2015 vs. 2014

Provision for income taxes was $25.1 million resulting in an effective tax rate of 127.4 percent compared to a provision of $3.6 million resulting in an effective tax rate of 6.3 percent for the three months ended September 30, 2015 and 2014, respectively. Excluding discrete items, the effective rate is (10.3)% compared to 27.1% for the three months ended September 30, 2015 and 2014, respectively. A more detailed description of the change and drivers to the change in the effective tax rate is included in Note 14 to the condensed consolidated financial statements included within this Form 10-Q.

### Nine months ended September 30, 2015 vs. 2014

Income tax benefit was $56.4 million resulting in an effective tax rate of 104.4% compared to a provision of $74.6 million resulting in an effective tax rate of 23.1% for the nine months ended September 30, 2015 and 2014, respectively. Excluding discrete items, the effective rate is 21.4% compared to 26.6% for the nine months ended September 30, 2015 and 2014, respectively. A more detailed description of the change and drivers to the change in the effective tax rate is included in Note 14 to the condensed consolidated financial statements included within this Form 10-Q.

#### Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Alkali Chemicals and FMC Peroxygens divisions' results as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

### Three months ended September 30, 2015 vs. 2014

Discontinued operations, net of income taxes represented a loss of $5.0 million for the three months ended September 30, 2015, compared to a gain of $6.4 million for the three months ended September 30, 2014. The change was driven by the discontinued operations of our FMC Alkali Chemicals division which were included in the three months ended September 30, 2014. Since the sale of our FMC Alkali Chemicals division was completed on April 1, 2015 the three months ended September 30, 2015 did not include any operating results of FMC Alkali Chemicals. For more information on our discontinued operations, net of income taxes, see Note 9 to the condensed consolidated financial statements included in this Form 10-Q.

### Nine months ended September 30, 2015 vs. 2014

Discontinued operations, net of income taxes represented a gain of $698.8 million for the nine months ended September 30, 2015, compared to a loss of $4.9 million for the nine months ended September 30, 2014. The change was driven by the divestiture of our FMC Alkali Chemicals division in the nine months ended September 30, 2015 which resulted in an after tax gain of $702 million in 2015.

#### Net income (loss) attributable to FMC stockholders

### Three months ended September 30, 2015 vs. 2014

Net income attributable to FMC stockholders decreased to a loss of $2.4 million from income of $56.3 million. The decrease was primarily driven by lower segment operating profit in FMC Agricultural Solutions.

### Nine months ended September 30, 2015 vs. 2014

Net income attributable to FMC stockholders increased to $693.1 million from $231.0 million. The increase was primarily due to the gain from the sale of our FMC Alkali Chemicals division as described above.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2015 and December 31, 2014, were $173.7 million and $109.5 million, respectively. Of the cash and cash equivalents balance at September 30, 2015, $118.5 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings.

At September 30, 2015, we had total debt of $2,169.7 million as compared to $1,678.6 million at December 31, 2014. Total debt included $2,048.5 million and $1,153.4 million of long-term debt (excluding current portions of $1.4 million and $2.0 million) at September 30, 2015 and December 31, 2014, respectively. As of September 30, 2015, we were in compliance with all of our debt covenants. See Note 8 in the condensed consolidated financial statements included in this Form 10-Q for further details.

The increase in long-term debt was due to borrowings of $1.65 billion under our senior unsecured Term Loan Facility. The proceeds of the borrowing were used to finance the acquisition of Cheminova as well as to pay costs, fees and expenses incurred in connection with the acquisition and the term loan facility. At September 30, 2015, $900.0 million remained outstanding under the Term Loan facility, as a portion of the net proceeds from the sale of our FMC Alkali Chemicals division (see Note 9 in the condensed consolidated financial statements included in this Form 10-Q for further details) was used to pay down the initial borrowings. The scheduled maturity of the Term Loan Facility is on April 21, 2020. The borrowings under the Term Loan Agreement will bear interest at a floating rate, which will be a base rate or a Eurocurrency rate equal to the London interbank offered rate for the relevant interest period, plus in each case an applicable margin, as determined in accordance with the provisions of the Term Loan Agreement. See Note 8 in the condensed consolidated financial statements included in this Form 10-Q for further details.

Short-term debt, which consists of borrowings under our commercial paper program as well as short-term foreign borrowings, decreased from $523.2 million at December 31, 2014 to $119.8 million at September 30, 2015. A portion of the proceeds from the sale of our FMC Alkali Chemicals was utilized to pay down outstanding borrowings under our commercial paper program resulting in a reduction to short-term borrowings from December 31, 2014 to September 30, 2015.

Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At September 30, 2015, the average effective interest rate on these borrowings was 0.52%.

### Statement of Cash Flows

*Cash provided (required) by operating activities of continuing operations was $(246.8) million and $132.4 million for the nine months ended September 30, 2015 and 2014, respectively.*

The table below presents the components of net cash provided (required) by operating activities of continuing operations.

*(in Millions)*

| 2015 | Nine Months Ended September 30 | 2014 |
| --- | ---: | ---: |
| Income (loss) from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $4.9 | $360.7 |
| Significant non-cash expenses (1) | 187.2 | 105.2 |
| **Operating income before non-cash expenses (Non-GAAP)** | **$192.1** | **$465.9** |
| Change in trade receivables (2) | 315.5 | (98.0) |
| Change in inventories (3) | (8.0) | (73.4) |
| Change in accounts payable (4) | (201.1) | 2.6 |
| Change in accrued rebates (5) | 112.3 | 144.0 |
| Change in advance payments from customers (6) | (186.2) | (174.8) |
| Change in all other operating assets and liabilities (7) | (25.4) | 79.1 |
| Restructuring and other spending (8) | (22.3) | (6.6) |
| Environmental spending, continuing, net of recoveries (9) | (18.6) | (9.1) |
| Pension and other postretirement benefit contributions (10) | (71.0) | (65.2) |
| **Cash basis operating income (Non-GAAP)** | **$87.3** | **$264.5** |
| Interest payments | (61.9) | (43.2) |
| Tax payments | (270.6) | (84.5) |
| Excess tax benefits from share-based compensation | (1.6) | (4.4) |
| **Cash provided (required) by operating activities of continuing operations** | **$(246.8)** | **$132.4** |

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) The decrease in trade receivables in 2015 was primarily driven by reduced revenue growth in FMC Agricultural Solutions mostly related to Brazil as well as to a lesser extent timing of collections. Collection timing is more pronounced in our FMC Agricultural Solutions business where sales, particularly in Brazil, have terms significantly longer than the rest of our businesses. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks.

(3) Inventory levels increased slightly in 2015 due to overall inventory reductions, compared to last year, as the inventory levels were adjusted to take into consideration the change in market conditions. The change in inventory for 2014 was primarily due to an inventory build to fulfill projected demand in the second half of 2014 in FMC Agricultural Solutions and FMC Health and Nutrition.

(4) The decrease in accounts payable balances during 2015 is primarily due to timing of payments including inventory reductions activities across the company, particularly as we integrate Cheminova as well as proactively adjust inventory levels in light of current market conditions.

(5) These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil and generally settle in the fourth quarter of each year.

(6) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. During the past two years we received substantial increases in advance payments from customers at the end of the preceding years for the subsequent years planting season.

(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities. The nine months of 2015 was primarily impacted by the payments of $264.8 million for the Cheminova purchase price hedges.

(8) See Note 7 in the condensed consolidated financial statements included in this Form 10-Q for further details.

(9) Included in our income presented for the nine months ended September 30, 2015 and September 30, 2014 are environmental charges for environmental remediation at our operating sites of $2.9 million and $17.3 million, respectively. The amounts in 2015 will be spent in periods beyond the second quarter of 2015. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(10) Amounts include voluntary contributions to our U.S. defined benefit plan of $65.0 million and $50.0 million, respectively.

*Cash provided (required) by operating activities of discontinued operations was $(63.7) million and $69.3 million for the nine months ended September 30, 2015 and 2014, respectively.*

The increase of cash required by operating activities of discontinued operations in 2015 is due primarily to divestiture costs associated with the sale of our FMC Alkali Chemicals business on April 1, 2015 which was previously classified as a discontinued operation.

*Cash required by investing activities of continuing operations was $1,281.7 million and $167.8 million for the nine months ended September 30, 2015 and 2014, respectively.*

The increase in spending during the nine months ended September 30, 2015, as compared to the same period in 2014 was due to the Cheminova acquisition on April 21, 2015 for an aggregate purchase price of $1.2 billion, excluding assumed net debt and hedged-related costs totaling $0.6 billion

*Cash provided by investing activities of discontinued operations was $1,634.3 million and $168.4 million for the nine months ended September 30, 2015 and 2014, respectively.*

Cash provided by investing activities of discontinued operations in 2015 is directly associated with the sale of our FMC Alkali Chemicals business which was completed on April 1, 2015. Cash provided by investing activities of discontinued operations in 2014 is directly associated with the sale of our FMC Peroxygens business which was completed on February 28, 2014. For more information see Note 9 to the condensed consolidated financial statements included in this Form 10-Q.

*Cash provided (required) by financing activities was $28.0 million and $(199.6) million for the nine months ended September 30, 2015 and 2014, respectively.*

The change period over period in financing activities is primarily due to the $1.65 billion we borrowed under our previously announced senior unsecured Term Loan facility. The proceeds of the borrowing were used to finance the acquisition of Cheminova as well as to pay costs, fees and expenses incurred in connection with the acquisition and the term loan facility. In 2015 borrowings were approximately $88 million compared to repayments in 2014 of $119 million.

### Other potential liquidity needs

Our cash needs outside of the Cheminova acquisition and related integration expenses for 2015 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2015, our remaining borrowing capacity under our credit facility was $1,419.4 million (which includes borrowings under our commercial paper program).

As discussed throughout this 10-Q, we closed on the Cheminova acquisition in April of 2015 as well as completed the sale of our FMC Alkali Chemicals division in that same month. The proceeds from the FMC Alkali Chemicals sale as well as borrowings under our term loan facility were used to finance the acquisition. See Note 8 to the condensed consolidated financial statements included within this Form 10-Q for more detail on the term loan.

Projected 2015 capital expenditures as well as expenditures related to contract manufacturers are expected to be lower than 2014 levels. This includes expected spending for Cheminova subsequent to the acquisition.

Projected 2015 spending includes approximately $50 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through September 30, 2015 and 2014 of $65.0 million and $50.0 million, respectively. These contributions are in excess of the minimum requirements. We do not expect to make any further contributions to our U.S. defined benefit pension plan during 2015.

For the nine months ended September 30, 2015 and 2014, we paid $64.3 million and $58.1 million, respectively, in dividends declared. On October 15, 2015, we paid dividends totaling $22.1 million to our shareholders of record as of September 30, 2015. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2015.

During the nine months ended September 30, 2015, no shares were repurchased under the publicly announced repurchase program. At September 30, 2015, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

### Commitments and Contingencies

See Note 16 to the condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2014 can be found in a table included within Part II, Item 7 of our 2014 Form 10-K. There have been no significant changes to our contractual commitments during the nine months ended September 30, 2015.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2014 Form 10-K. Our former FMC Alkali Chemicals division mined and refined trona ore into soda ash, and this activity constituted most of FMC’s greenhouse gas emissions globally. The sale of our Alkali Chemicals Division was completed on April 1, 2015 as discussed further in Note 9 to the condensed consolidated financial statements included within this Form 10-Q. As a result, we no longer have the level of greenhouse gas emissions that were previously driven by this business.

On April 21, 2015, we completed the acquisition of Cheminova as discussed further in Note 3 to the condensed consolidated financial statements included within this Form 10-Q. Cheminova has foreign operations with multiple plants, which may be subject to national or local energy management or climate change regulation. Therefore, we will evaluate any such regulations at these facilities and will routinely assess the consequences of potential future climate change on our operations.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 15 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2015, our financial instrument position was a net asset of $15.5 million compared to a net liability of $92.5 million at December 31, 2014. The change in the net financial instrument position was primarily due to the settlement of outstanding hedges for the purchase price of Cheminova, see Note 3 to the condensed consolidated financial statement included within this Form 10-Q for more information.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2015 and December 31, 2014, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at September 30, 2015** | $(1.6) | $(0.8) | $(2.3) |
| **Net asset/(liability) position at December 31, 2014** | $(7.3) | $(5.3) | $(9.4) |

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of September 30, 2015 and December 31, 2014 our net financial instrument position was immaterial.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan, the U.S. dollar versus the Brazilian real and the U.S. dollar versus the Argentine peso. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2015 and December 31, 2014, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged Currency vs. Functional Currency 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset/(liability) position at September 30, 2015** | $17.1 | $44.3 | $(10.4) |
| **Net asset/(liability) position at December 31, 2014 (1)** | $(85.2) | $91.3 | $(261.0) |

(1) Includes the unrealized loss on hedging the purchase price of Cheminova as of December 31, 2014. See "Cheminova Acquisition Hedge Costs" in Note 3 to the condensed consolidated financial statements included in this Form 10-Q.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2015 and December 31, 2014, we had no interest rate swap agreements.

Our debt portfolio, at September 30, 2015, is composed of 55 percent fixed-rate debt and 45 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Term Loan Facility, Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at September 30, 2015, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $7.3 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $2.1 million for the nine months of September 30, 2015.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 4,648 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2015, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. As further discussed in Note 3 to the condensed consolidated financial statements included within this Form 10-Q, we completed the acquisition of Cheminova on April 21, 2015. We have begun the process of analyzing Cheminova’s systems of disclosure controls and procedures and internal controls over financial reporting and integrating them within our framework of controls. Accordingly, pursuant to SEC guidance that an assessment of a recently acquired business may be omitted from the scope of an assessment for up to one year following the date of acquisition, the scope of our assessment of the effectiveness of our disclosure controls and procedures does not include any disclosure controls and procedures of Cheminova that are also part of Cheminova's internal control over financial reporting.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2015, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting. The Company is currently evaluating Cheminova's processes, information technology systems, and other components of internal controls over financial reporting as a part of the Company's integration activities which may result in periodic control changes. Such changes will be disclosed as required by applicable SEC guidance.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2015, the related condensed consolidated statements of income (loss) and comprehensive income (loss), for the three-month and nine-month periods ended September 30, 2015 and 2014, and the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2015 and 2014. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2014, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 27, 2015, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2014, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

November 2, 2015

## Risk factors

As filed, 20,084 characters.

Subsequent to the acquisition of Cheminova and divestiture of our FMC Alkali Chemicals division (see Note 3 and Note 9 to the condensed consolidated financial statements included within this Form 10-Q for more information) we have reassessed our risk factors. Below lists our risk factors updated for these events.

Among the factors that could have an impact on our ability to achieve operating results and meet our other goals are:

#### Industry Risks:

Pricing and volumes in our markets are sensitive to a number of industry specific and global issues and events including:

- Capacity utilization - Our businesses are sensitive to industry capacity utilization. As a result, pricing tends to fluctuate when capacity utilization changes occur within our industry.
- Competition - All of our segments face competition, which could affect our ability to maintain or raise prices, successfully enter certain markets or retain our market position. Our FMC Agricultural Solutions, competition includes not only generic suppliers of the same pesticidal active ingredients, but also alternative proprietary pesticide chemistries, crop protection technologies that are bred into or applied onto seeds. Increased generic presence in agricultural chemical markets has been driven by the number of significant product patents and product data protections that have expired in the last decade, and this trend is expected to continue.
- Changes in our customer base - Our customer base has the potential to change, especially when long-term supply contracts are renegotiated. Our FMC Lithium and FMC Health and Nutrition businesses are most sensitive to this risk.
- Climatic conditions - Our FMC Agricultural Solutions markets are affected by climatic conditions, which could adversely impact crop pricing and pest infestations. Adverse weather conditions can impact our ability to extract lithium efficiently from our lithium reserves in Argentina. Natural disasters can impact production at our facilities in various parts of the world. The nature of these events makes them difficult to predict.
- Changing regulatory environment - Changes in the regulatory environment, particularly in the United States, Brazil, China and the European Union, could adversely impact our ability to continue producing and/or selling certain products in our domestic and foreign markets or could increase the cost of doing so. Our FMC Agricultural Solutions business is most sensitive to this general regulatory risk given the need to obtain and maintain pesticide registrations in every country in which we sell our products. Compliance with changing laws and regulations may involve significant costs or capital expenditures or require changes in business practice that could result in reduced profitability. In the European Union, the regulatory risk specifically includes chemicals regulation known as REACH (Registration, Evaluation, and Authorization of Chemicals), which affects each of our business segments to varying degrees. The fundamental principle behind the REACH regulation is that manufacturers must verify through a special registration system that their chemicals can be marketed safely.
- Geographic concentration - Although we have operations in most regions throughout the globe, the majority of our FMC Agricultural Solutions sales outside the United States have principally been to customers in Latin America, including Brazil, Argentina and Mexico. With the acquisition of Cheminova, we are expanding our international sales, particularly in Europe and key Asian countries such as India. Accordingly, developments in those parts of the world will generally have a more significant effect on our operations. Our operations outside the United States are subject to special risks and restrictions, including: fluctuations in currency values; exchange control regulations; changes in local political or economic conditions; governmental pricing directives; import and trade restrictions; import or export licensing requirements and trade policy; restrictions on the ability to repatriate funds; and other potentially detrimental domestic and foreign governmental practices or policies affecting U.S. companies doing business abroad.
- Food and pharmaceutical regulation - Some of our manufacturing processes and facilities, as well as some of our customers, are subject to regulation by the U.S. Food and Drug Administration (FDA) or similar foreign agencies. Regulatory requirements of the FDA are complex, and any failure to comply with them including as a result of contamination due

to acts of sabotage could subject us and/or our customers to fines, injunctions, civil penalties, lawsuits, recall or seizure of products, total or partial suspension of production, denial of government approvals, withdrawal of marketing approvals and criminal prosecution. Any of these actions could adversely impact our net sales, undermine goodwill established with our customers, damage commercial prospects for our products and materially adversely affect our results of operations.

- Climate change regulation - Changes in the regulation of greenhouse gases, depending on their nature and scope, could subject our manufacturing operations to significant additional costs or limits on operations.
- Fluctuations in commodity prices - Our operating results could be significantly affected by the cost of commodities such as raw materials and energy, including natural gas. We may not be able to raise prices or improve productivity sufficiently to offset future increases in commodity pricing. Accordingly, increases in commodity prices may negatively affect our financial results. Where practical, we use hedging strategies to address material commodity price risks, where hedge strategies are available on reasonable terms. We also use raw material supply agreements that contain terms designed to mitigate the risk of short-term changes in commodity prices. However, we are unable to avoid the risk of medium- and long-term increases. Additionally, fluctuations in commodity prices could negatively impact our customers' ability to sell their product at previously forecasted prices resulting in reduced customer liquidity. Inadequate customer liquidity could affect our customers’ abilities to pay for our products and, therefore, affect existing and future sales or our ability to collect on customer receivables.
- Supply arrangements - Certain raw materials are critical to our production process. While we have made supply arrangements to meet planned operating requirements, an inability to obtain the critical raw materials or operate under contract manufacturing arrangements would adversely impact our ability to produce certain products. We increasingly source critical intermediates and finished products from a number of suppliers. An inability to obtain these products or execute under contract sourcing arrangements would adversely impact our ability to sell products. In FMC Lithium geological conditions can affect production of raw materials.
- Economic and political change - Our business could be adversely affected by economic and political changes in the markets where we compete including: inflation rates, recessions, trade restrictions, foreign ownership restrictions and economic embargoes imposed by the United States or any of the foreign countries in which we do business; changes in laws, taxation, and regulations and the interpretation and application of these laws, taxes, and regulations; restrictions imposed by foreign governments through exchange controls or taxation policy; nationalization or expropriation of property, undeveloped property rights, and legal systems or political instability; other governmental actions; and other external factors over which we have no control. Economic and political conditions within foreign jurisdictions or strained relations between countries can cause fluctuations in demand, price volatility, supply disruptions, or loss of property. In Argentina, continued inflation and tightening of foreign exchange controls along with deteriorating economic and financial conditions could adversely affect our business.

#### Operational Risks:

- Market access risk - Our results may be affected by changes in distribution channels, which could impact our ability to access the market.
- Business disruptions - Although more recently, FMC Agricultural Solutions has engaged in pesticide active ingredient contract manufacturing rather than owned and operated FMC own manufacturing facilities, Cheminova owns and operates large-scale manufacturing facilities in Denmark and India. This will present us with additional operating risks, in that our operating results will be dependent in part on the continued operation of the various acquired production facilities and the ability to manufacture products on schedule. Interruptions at these facilities may materially reduce the productivity and profitability of a particular manufacturing facility, or our business as a whole, during and after the period of such operational difficulties. Although we take precautions to enhance the safety of our operations and minimize the risk of disruptions, our operations and those of our contract manufacturers are subject to hazards inherent in chemical manufacturing and the related storage and transportation of raw materials, products and wastes. These potential hazards include explosions, fires, severe weather and natural disasters, mechanical failure, unscheduled downtimes, supplier disruptions, labor shortages or other labor difficulties, information technology systems outages, disruption in our supply chain or manufacturing and distribution operations, transportation interruptions, chemical spills, discharges or releases of toxic or hazardous substances or gases, shipment of incorrect or off-specification product to customers, storage tank leaks, other environmental risks, or other sudden disruption in business operations beyond our control as a result of events such as acts of sabotage, terrorism or war, civil or political unrest, natural disasters, pandemic situations and large scale power outages. Some of these hazards may cause severe damage to or destruction of property and equipment or personal injury and loss of life and may result in suspension of operations or the shutdown of affected facilities.
- Information technology security risks - As with all enterprise information systems, our information technology systems could be penetrated by outside parties intent on extracting information, corrupting information, or disrupting business processes. Our systems have in the past been, and likely will in the future be, subject to unauthorized access attempts. Unauthorized access could disrupt our business operations and could result in failures or interruptions in our computer

systems and in the loss of assets and could have a material adverse effect on our business, financial condition or results of operations. In addition, breaches of our security measures or the accidental loss, inadvertent disclosure, or unapproved dissemination of proprietary information or sensitive or confidential information about us, our employees, our vendors, or our customers, could result in litigation and potential liability for us, damage our reputation, or otherwise harm our business, financial condition, or results of operations.

- Capital-intensive business - With the acquisition of Cheminova, our business is more capital intensive than it has been historically. We rely on cash generated from operations and external financing to fund our growth and ongoing capital needs. Limitations on access to external financing could adversely affect our operating results. Moreover, interest payments, dividends and the expansion of our business or other business opportunities may require significant amounts of capital. We believe that our cash from operations and available borrowings under our revolving credit facility will be sufficient to meet these needs in the foreseeable future. However, if we need external financing, our access to credit markets and pricing of our capital will be dependent upon maintaining sufficient credit ratings from credit rating agencies and the state of the capital markets generally. There can be no assurances that we would be able to obtain equity or debt financing on terms we deem acceptable, and it is possible that the cost of any financings could increase significantly, thereby increasing our expenses and decreasing our net income. If we are unable to generate sufficient cash flow or raise adequate external financing, including as a result of significant disruptions in the global credit markets, we could be forced to restrict our operations and growth opportunities, which could adversely affect our operating results.

We may use our $1.5 billion revolving credit facility to meet our cash needs, to the extent available. As of September 30, 2015, we had unused and available credit capacity of $1.4 billion. In the event of a default under our credit facility or any of our senior notes, we could be required to immediately repay all outstanding borrowings and make cash deposits as collateral for all obligations the facility supports, which we may not be able to do. Any default under any of our credit arrangements could cause a default under many of our other credit agreements and debt instruments. Without waivers from lenders party to those agreements, any such default could have a material adverse effect on our ability to continue to operate.

- Litigation and environmental risks - Current reserves relating to our ongoing litigation and environmental liabilities may ultimately prove to be inadequate.
- Hazardous materials - We manufacture and transport certain materials that are inherently hazardous due to their toxic or volatile nature. While we take precautions to handle and transport these materials in a safe manner, if they are mishandled or released into the environment, they could cause property damage or personal injury claims against us.
- Environmental Compliance - We are subject to extensive federal, state, local, and foreign environmental and safety laws. regulations, directives, rules and ordinances concerning, among other things, emissions in the air, discharges to land and water, and the generation, handling, treatment, disposal and remediation of hazardous waste and other materials. We may face liability arising out of the normal course of business, including alleged personal injury or property damage due to exposure to chemicals or other hazardous substances at our current or former facilities or chemicals that we manufacture, handle or own. We take our environmental responsibilities very seriously, but there is a risk of environmental impact inherent in our manufacturing operations and transportation of chemicals. Any substantial liability for environmental damage could have a material adverse effect on our financial condition, results of operations and cash flows.
- Inability to attract and retain key employees - The inability to recruit and retain key personnel or the unexpected loss of key personnel may adversely affect our operations. In addition, our future success depends in part on our ability to identify and develop talent to succeed senior management.

#### Technology Risks:

- Our ability to compete successfully depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize new and innovative, high value-added products for existing and future customers.
- Failure to continue to make process improvements to reduce costs could impede our competitive position.
- Some of our competitors may secure patents on production methods or uses of products that may limit our ability to compete cost-effectively.

#### Portfolio Management Risks:

- We continuously review our portfolio which includes the evaluation of potential business acquisitions that may strategically fit our business and strategic growth initiatives. If we are unable to successfully integrate and develop our acquired businesses, we could fail to achieve anticipated synergies which would include expected cost savings and revenue growth. Failure to achieve these anticipated synergies, could materially and adversely affect our financial results. In addition to strategic acquisitions we evaluate the diversity of our portfolio in light of our objectives and alignment with our growth strategy. In implementing this strategy we may not be successful in separating underperforming or non-

strategic assets and gains or losses on the divestiture of, or lost operating income from, such assets may affect the company’s earnings. Moreover, we may incur asset impairment charges related to acquisitions or divestitures that reduce its earnings.

In particular, inability to successfully integrate and develop Cheminova as planned could result in our inability to achieve the synergies we have projected and could thereby cause our future results of operations to be materially and adversely worse than expected. We expect to generate synergies as a result of i) improving Cheminova operating cost-efficiencies, ii) changing the mix of Cheminova’s sales from generic, lower margin products to more differentiated and higher margin products, and iii) rationalizing of distribution channels used by FMC and Cheminova in overlapping European markets. However, there can be no assurances that we will be successful in achieving these planned synergies.

#### Financial Risks:

- Deterioration in the global economy and worldwide credit and foreign exchange markets could adversely affect our business. A worsening of global or regional economic conditions or financial markets could adversely affect our customers' ability to meet the terms of sale or our suppliers' ability to perform all their commitments to us. A slowdown in economic growth in our international markets, particularly Latin American regions, or a deterioration of credit or foreign exchange markets could adversely affect customers, suppliers and our overall business there. Customers in weakened economies may be unable to purchase our products, or it could become more expensive for them to purchase imported products in their local currency, or sell their commodities at prevailing international prices, and we may be unable to collect receivables from such customers.
- We are an international company and face foreign exchange rate risks in the normal course of our business. We are particularly sensitive to the euro, the Brazilian real and the Chinese yuan. To a lesser extent, we are sensitive to the Mexican peso, the Argentine peso, the British pound sterling and several Asian currencies, including the Japanese yen. Our acquisition of Cheminova has significantly expanded our operations and sales in foreign countries and correspondingly increased our exposure to foreign exchange risks.
- Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance; changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States taxes have not been previously accrued.
- We have significant investments in long-lived assets and continually review the carrying value of these assets for recoverability in light of changing market conditions and alternative product sourcing opportunities.
- Obligations related to our pension and postretirement plans reflect certain assumptions. To the extent our plans' actual experience differs from these assumptions, our costs and funding obligations could increase or decrease significantly.

Filed Nov 2, 2015.
Source: SEC EDGAR, the filing index for accession 0000037785-15-000077. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
